CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the molecular mechanisms of treatment response in metastatic prostate cancer. It aims to identify predictive biomarkers using patient-derived models to guide personalized therapy and improve patient outcomes.
Prostate cancer (PC) is among the top five leading malignancies causing cancer mortality worldwide.
Increased prevalence and declined mortality rate have led to an increment in follow-ups with a significant rise in the economic burden.
In the last few years, several new options for metastatic disease have been approved leading to clinicians to have multiple choices of therapy sequences.
However, not all patients initially respond and most of them eventually develop resistance.
The ability of tum…
FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Australia, Victoria
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
